Structure Therapeutics Inc. (GPCR) Most Active Options

The 25 most actively traded Structure Therapeutics Inc. (GPCR) option contracts at the latest daily snapshot, ranked by volume. Each row shows the contract's price, implied volatility, delta, open interest, and how today's volume compares with its own 30-day average — click a contract to analyze it in the OptiView platform.

Data as of Jul 10, 2026, 8:00 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.

Last close
$53.18
52-week range
$16.22 – $93.90
ATM IV (30d)
87.9%
IV rank
72 / 100
High
Expected move
±$6.47 (±12.2%)
Put/call OI
0.23
Call-heavy
Max pain
$42.5
↓ 20.1% below close
Next earnings
Aug 9, 2026

Most Active GPCR Contracts

ContractExpirationDTELastIV IV rank (30d)DeltaOpen interestVolumevs 30d avg
GPCR $47.5 call Jul 17, 2026 7d $6.10 128.3% 100 0.76 280 96 4.2× avg
GPCR $60 call Aug 21, 2026 42d $3.50 96.6% 100 0.42 57 15 1.4× avg
GPCR $100 call Jan 21, 2028 560d $11.15 79.5% 14 0.46 29 10 4.8× avg
GPCR $60 call Jul 17, 2026 7d $0.05 100.0% 39 0.20 277 10 0.5× avg
GPCR $65 call Jul 17, 2026 7d $0.20 133.5% 31 0.15 378 10 0.2× avg
GPCR $70 call Jan 21, 2028 560d $16.85 81.4% 35 0.61 41 10 1.5× avg
GPCR $50 call Jul 17, 2026 7d $4.00 86.9% 0 0.70 402 8 0.4× avg
GPCR $52.5 call Jul 17, 2026 7d $2.42 87.9% 0 0.55 77 7 1.4× avg
GPCR $55 call Jul 17, 2026 7d $1.50 54.7% 0 0.32 263 7 2.3× avg
GPCR $55 call Aug 21, 2026 42d $5.39 80.4% 62 0.50 32 7 1.2× avg
GPCR $42.5 call Jan 15, 2027 189d $18.20 93.5% 80 0.75 22 5 3.2× avg
GPCR $52.5 call Aug 21, 2026 42d $6.68 89.4% 87 0.58 5 5 3.8× avg
GPCR $42.5 put Jul 17, 2026 7d $0.05 175.8% 39 -0.15 72 4 0.4× avg
GPCR $75 call Jul 17, 2026 7d $0.25 189.2% 67 0.12 422 3 0.1× avg
GPCR $45 put Aug 21, 2026 42d $2.20 85.0% 39 -0.24 3 2 0.8× avg
GPCR $52.5 put Oct 16, 2026 98d $9.21 87.0% 51 -0.40 0 2 2.2× avg
GPCR $50 call Jan 21, 2028 560d $22.33 82.3% 48 0.73 68 2 2.3× avg
GPCR $45 call Oct 16, 2026 98d $13.70 90.6% 72 0.73 44 2 1.3× avg
GPCR $20 call Jan 21, 2028 560d $35.75 94.7% 70 0.93 3 1 0.9× avg
GPCR $30 call Jan 21, 2028 560d $31.20 86.7% 64 0.87 8 1 0.9× avg
GPCR $40 call Jan 21, 2028 560d $25.91 84.5% 62 0.80 19 1 0.9× avg
GPCR $40 put Jul 17, 2026 7d $0.45 206.0% 56 -0.13 69 1 0.1× avg
GPCR $30 call Oct 16, 2026 98d $24.00 106.1% 78 0.91 527 1 0.9× avg
GPCR $35 put Jul 17, 2026 7d $0.40 199.7% 8 -0.05 45 1 9.0× avg
GPCR $35 put Oct 16, 2026 98d $1.75 93.1% 33 -0.13 104 1 6.6× avg

Ranked by volume at the latest daily snapshot. "vs 30d avg" compares today's volume with the contract's own 30-day average.

The most active GPCR contract today is the $47.5 call expiring in 7 days, with 96 contracts traded. Calls dominate the most-active list (19 of the top 25), showing where trading interest concentrates.

Explore the payoff profile of option on GPCR for free

Build multi-leg GPCR strategies, visualize payoffs, and scan the full US options universe with OptiView.

GPCR Options FAQ

Which GPCR option contract is most active today?

The most traded GPCR contract is the $47.5 call expiring Jul 17, 2026, with 96 contracts traded as of Jul 10, 2026.

How does OptiView rank the most active GPCR options?

The table lists the 25 GPCR contracts with the highest volume at the latest daily snapshot, alongside price, implied volatility, delta, open interest, and each contract's volume versus its own 30-day average.

Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.

Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.